We are an ESG led company and impact investment opportunity; we support the United Nation's Sustainable Development Goals to achieve a better future for all.
We create hope for patients by developing biosimilars for the most complex diseases and address the world’s largest health problems.
We support the United Nation's Sustainable Development Goals, the blueprint to achieving a better and more sustainable future for all.
In order to protect the environment, Singapore Biotech has established an environmental management system, ISO14001, and complies with international and national environmental requirements. Our state-of-the-art manufacturing facilities incorporate green practices in building design.
We prevent contamination of the environment through optimal use of resources and energy as well as reducing and removing potentially harmful and adverse environmental effects of new development projects. Our company has adopted environmentally safe waste management procedures as well as a a commitment to reduce waste generation overall.
Our inclusive and high-performing work environment, as well as a commitment to provide learning, training, and development opportunities to help employees advance their careers result in a very motivated workforce that allows us to achieve our business objectives.
The high retention rate of our employees is also due to the fact that we truly believe in our values of Integrity, Innovation, Quality, Sustainability, and Hope. These values are what defines us and create a common bond amongst us. They motivate us to develop new and better medicines that are changing lives by making quality treatments more accessible and more affordable to all people.
Our fundamental belief is that everyone should have access to high-quality medicines.
The company’s ESG policies are followed in all facets of the decision making process, and our decisions are guided by the social impact our medicines will have on global health.
Our governance systems encourage the company’s ongoing pursuit to innovate, which is critical to our success and to create shareholder value. Most importantly, it enables us to bring effective and affordable medicines to market globally.